مدیرعامل شرکت Insilico امیدوار است پس از نتایج امیدوارکننده از آزمایش داروی فیبروز، «شاید فرصتی برای توقف پیری بیولوژیکی داشته باشیم».

Insilico’s co-CEO hopes ‘we might have a chance to stop biological aging’ after promising results from its fibrosis drug trial

Drugmakers hope they can ease Asia's healthcare burden by tackling aging at its source, and one says it now has early evidence it's possible.